Published in Gene Therapy Weekly, May 4th, 2000
"Recombinant eNOS gene transfer is being investigated as a putative therapeutic option for cardiovascular diseases, including cerebral vasospasm," noted Vini G. Khurana and colleagues from Mayo Clinic, Minnesota, USA. "The aim of the present study was to determine the effects of recombinant eNOS gene transfer on vascular reactivity of normal human cerebral arteries."
The researchers conducted isometric force recording of isolated pial arteries (sized 500-1000...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.